Improving the Efficacy of Double-negative T-Cells (DNTs) Against Lung Cancer: Chimeric Antigen Receptor-transduced DNTs as a Potential Treatment
Year: 2021
Type: dissertation
Abstract: Lung cancer is the leading cause of cancer-related mortalities, and better treatments are required. Double-negative T-cells (DNTs) are CD3+CD4-CD8- T-cells with potential as an off-the-shelf cellular therapy. They exhibit antitumor activity against lung cancer, but are not curative. Existing DNT potency can thus be improved, such as by the addition of a chimeric antigen receptor (CAR). CAR T-cell therapy is highly effective for hematological malignancies but shows limited success in solid tumors. In this study, anti-CD19 CAR (CAR19)-DNTs were significantly more cytotoxic than non-transduced (NT)-DNTs against A549 lung cancer cells modified to express CD19. CAR19-DNTs safely and effectively inhibited A549-CD19 tumor growth in a xenograft model and displayed increased tumor infiltration compared to NT-DNTs. We demonstrated for the first time that DNT cytotoxicity against lung cancer can be enhanced by a CAR, and CAR-DNTs may be an effective treatment for solid tumors if the cancer expresses an appropriate target antigen.
Source: TSpace (University of Toronto)
Author: Leung, Yuki Sze Long
Institution: University of Toronto
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7133072035
